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THE CHRONOTROPIC ACTION OF VERATRIDINE
STUDIED BY DIRECT PERFUSION OF THE
SINUS NODE THROUGH ITS ARTERY
THOMAS N . JAMES, M.D. AND REGINALD A. NADEAU, M.D.

VERATRIDINE AND RELATED veratrum alkaloids have so many dramatic effects on the
cardiovascular system that it is difficult to separate those which are primary from those
which are secondary. With an experimental preparation permitting direct perfusion
of the sinus node through its own artery we have studied the chronotropic action of
veratridine and compared it to that of veratramine. Because nodal perfusion was
direct, sufficiently small quantities of test substances could be employed so that on
re-circulation they had no discernible effect on ventricular myocardium or extracardiac neuroreceptors.
METHOD

Nine dogs were anesthetized with intraperitoneal pentobarbital (30 mg/kg) and the
trachea intubated for mechanical ventilation. Through a midline sternal-splitting incision
the heart was exposed and cradled in the pericardial sac. The right coronary artery was
dissected free between the atrial appendage and the margo acutus, and a small polyethylene cannula inserted into an opening cut in the artery and passed up its sinus node
branch'^ Collateral arterial circulation to the canine sinus node is so extensive that
ligation of its primary arterial supply during cannulation has no significant effect on
either rate or rhythm of the sinus node^ Details of the method have been published
previously*'.
For nerve stimulation the right vagus was isolated in the mid-cervical region and
the right stellate ganglion within the thorax. Stimuli were delivered in rectangular waves,
30 cps, for 6 second trains of 1 miOisecond impulses. Cannulae were routinely placed in
the right atrium via the jugular vein and central aorta via the femoral artery. Throughout
the experiments central aortic and central venous pressures were measured with transducers and monitored simultaneously with an electrocardiogram and tachogram on an
oscilloscope at 50 mm/second. These phenomena were constantly recorded on a master
recorder at 0.25 mm/second, with a slave circuit to a one-channel direct writing elecFrom the Section on Cardiovascular Research.
This work was supported in part by grants from the United States Public Health Service and the
Michigan Heart Association. Dr. Nadeau is a Michigan Heart Association Research Fellow.
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trocardiograph permitting a separate permanent record (at 25 mm/second) from which
the electrocardiographic complexes could later be studied. The tachogram was derived
with an analog computer from successive R waves of the electrocardiogram and reflected
instantaneously any change in heart rate. Final records of heart rate change were additionally plotted and graphed from each experiment as the average rate in successive
6-second intervals of the 25 mm/second electrocardiogram, where any changes in
rhythm could be determined.
Veratridine hydrochloride* for injection into the sinus node artery was prepared
by dilution with Ringer's solution in logarithmically increased concentrations from
0.001 to 1.0 /ig/ml; similar concentrations were prepared in fresh autogenous arterial
blood. Veratramine hydrochloride* was also prepared both in blood and Ringer's
solution, in the same concentrations. Veratridine was studied in all nine dogs, and compared to veratramine in four. The injections into the sinus node artery were delivered
from a hand syringe directly into the polyethylene cannula in 1.0 ml. volume in 30
seconds. Second and subsequent injections were made only after the heart rate had
returned lo control. When more than one series of increasing concentrations of test
substance was given the same dog, at least one hour was allowed to elapse between
series. Serial injections of veratridine or veratramine at concentrations of 1.0 /"g/ml
were administered as soon as heart rate returned to control.
RESULTS

In this experimental preparation any injection directly into the sinus node artery
causes an initial slowing of sinus rate, followed regularly by a slight post-injection
acceleration from Ringer's or Krebs-Henseleit solution, but rarely when injections are
in fresh autogenous arterial blood^ Neither veratridine nor veratramine at concentrations
of 0.001 Mg/ml had any effect different from control injections of Ringer's solution or
blood. With concentrations of 0.01 /^g/ml and greater there was no significant difference
between the chronotropic actions of veratridine and veratramine. Both substances produced sinus acceleration when administered in Ringer's solution (Figures 1, 2 ) , while
both caused sinus bradycardia if prepared in fresh autogenous arterial blood (Figures
3, 4 ) . None of the injections produced a significant change in right atrial or central
aortic pressure.
Sinus acceleration from the preparations in Ringer's solution was consistent at
1.0 Mg/ml but variable at lesser concentrations. In three of the nine dogs the degree
of acceleration increased with each effective concentration (0.01, 0.1 and 1.0 /^g/ml),
but in the others the acceleration at the two lower concentrations was either transiently
mixed with an associated period of slowing, or produced no more acceleration than the
control injection of Ringer's solution. The acceleration produced by 1.0 Mg/ml of either
veratridine or veratramine began during the period of injection (Figure 2), and was
in all respects identical to the type of acceleration observed in this same experimental
model from norepinephrine or isoproterenol'. This similarity includes the onset, peak
* Kindly supplied by Dr. Otto Krayer, Department of Pharmacology, Harvard Medical School,
Boston, Massachusetts.
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effect and duration of action as well as the concave slope in heart rate curve during
return to control. Acceleration in our experiments was observed without prior atropinization or vagotomy, conditions which have been reported to alter the chronotropic
response to veratridine'.
Sinus bradycardia from the preparations in blood consistently increased with each
increasing concentration of either veratridine or veratramine (Figure 3 ) . Atropinization
(0.2 mg/kg atropine sulfate) did not prevent this bradycardia. At concentrations of

AVERAGE MAXIMAL AND MINIMAL HEART RATES
AFTER INJECTION OF VERATRIDINE (IN RINGER'S)
INTO SINUS NODE ARTERY
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Figure 1
Veratridine in Ringer's solution injected into the sinus node artery produced sinus tachycardia, particularly evident with 1.0 /xg/ml. The variable responses at lower concentrations are discussed m
the text The vertical bars indicate the beats per minute above and below control rate (C). A
diphasic response in heart rate is characteristic of injections of Ringer's solution into the sinus node
arterys and the average responses plotted here for 0.01 and 0.1 Mg/ml of veraUidine are not
significandy different from responses to Ringer's solution alone. Veratramine in Ringers solution
had the same effect as veratridine.
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0.01 and 0.1 Mg/ml the slowing was entirely sinus bradycardia, while at 1.0 ."g/ml
there was sometimes transient sinus arrest with A-V nodal escape rhythm. Sinus bradycardia from either substance in blood was sometimes interrupted by transient periods
of acceleration, just as the acceleration of sinus rhythm from preparations in Ringer's
was sometimes interrupted by transient periods of bradycardia. However, the initial
injection of 1.0 /^g of veratridine or veratramine in Ringer's usually produced a pure
sinus tachycardia, while that in blood usually produced a pure sinus bradycardia.
COMPARISON OF THE POSITIVE CHRONOTROPIC ACTION
FROM SINUS NODE PERFUSION BY
VERATRAMINE, ISOPROTERENOL AND NOREPINEPHRINE

1 INJ 1

S

VERATRAMINE

ISOPROTERENOL

1.0 / i g

0.01 /ig

Figure 2
A characteristic response of heart rate to intranodal veratramine 1.0 /ig in Ringer's solution is
shown at the top of this graph; the same type of response was obtained with veratridine. This was
an uninterrupted sinus tachycardia which was in all features similar to the response obtained from
intranodal isoproterenol (middle graph) or norepinephrine (lower graph). The two lower graphs
are from the same dog and are typical of hundreds of similar injections', while the upper graph is a
different dog, but again typical of the veratridine-veratramine responses when administered in Ringer's
solution. Heart rate is plotted as the average in successive 6-second intervals of a 25 mm/second
electrocardiograph in which the P waves remained unchanged.
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For both veratridine and veratramine in Ringer's solution the time of onset and
duration of chronotropic action changed with increasing concentration of the test
substance. With both substances in concentrations of 0.01 and 0.1 Mg/ml in Ringer's
solution, the period of acceleration usually began near the end of the injection, or just
after its completion, and was therefore similar to the period of post-injection acceleration
from Ringer's solution alone, except of slightly longer duration. However, the sinus
acceleration from 1.0 Mg of either veratridine or veratramine in Ringer's solution began
early during the period of injection, and was usually maximal by the end of the
injection or shortly after it. Duration of this acceleration (averaging about 3 minutes
before return to control rate) was always longer than the post-injection acceleration seen
with control injections.

AVERAGE MAXIMAL AND MINIMAL HEART RATES
AFTER INJECTION OF VERATRIDINE (IN BLOOD) INTO
SINUS NODE ARTERY
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Figure 3
Veratridine prepared in fresh autogenous femoral artery blood produced increasing degrees of sinus
bradycardia in direct relation to tfie concntration. Compare in particular the difference in response
to I.O /ig here with that in Ringer's solution (Figure 1). Although some acceleration was apparent
with increasing concentrations in blood, the predominant effect is clearly one of slowing. The same
responses were obtained with veratramine in blood. The vertical bars indicate beats per minute
above and below control rate (C).
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CHRONOTROPIC EFFECT OF INCREASING CONCENTRATIONS OF
VERATRIDINE (IN BLOOD) INJECTED INTO SINUS NODE ARTERY

0\/i My

M I N U T E S

Figure 4
The increasing negative chronotropic effect of veratridine (or veratramine) in blood is demonstrated
in this graph of responses in one dog. Heart rate is plotted in the same manner as in Figure 2.

CHRONOTROPIC EFFECT OF TWO SUCCESSIVE INJECTIONS OF
VERATRAMINE 1.0
(IN RINGER'S) INTO SINUS NODE ARTERY

tJ
M I N U T E S

Figure 5
A comparison in one dog of the initial and second injections of veratramine 1.0 /ng in Ringer's
solution; the same effects were produced by veratridine in Ringer's solution. The initial accelerative
response shown on the left, which is an uninterrupted sinus tachycardia (same graph as top of
Figure 2), is replaced by an alternate acceleration and slowing foUowing the second injection.
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When given in blood, both veratridine and veratramine at concentrations of 0.01
and 0.1 /»g/ml again seemed only to exaggerate the normal response, i.e. they were
associated with more sinus bradycardia during the injection than was observed during
injections of blood alone. As with the injections in Ringer's solution at those concentrations, the duration of change corresponded generally to that observed from blood
alone, although again there was slight prolongation of this effect. The slowing effect
produced by 1.0 /^g of an initial injection of either test substance in blood was not only
much more profound during injection, but it always persisted after completion of the
injection, lasting three to 12 minutes before returning to control rate.
With serial injections of 1.0 ;iig of veratridine (3 dogs) or veratramine (2 dogs)
in blood the following pattern was usually observed. The first injection produced sinus
bradycardia alone, the next injection (after return to control rate) produced sinus
bradycardia with periodic rhythm and the slowing was usually more prolonged, while
the third injection usually produced sustained sinus arrest with escape A-V nodal rhythm.
Serial injection of 1.0 Mg of either substance in Ringer's solution characteristically had
the following effect (Figures 5, 6). The initial injection in Ringer's produced sinus
tachycardia instead of bradycardia; however, results of the second and third injections
were similar to the results of the second and third injections in blood, namely, predominant slowing plus periodic acceleration with the second injection, and usually sinus
arrest with A-V nodal escape rhythm following the third injection.
Because of the reported antiaccelerator effect of veratrum alkaloids as tested with
various adrenergic stimuli
the response to supramaximal stimulation of the stellate
ganglion was tested following intranodal veratridine in 2 dogs. In each of them
veratridine 1.0 ;ag abolished the acceleration from stellate stimulation with the response
gradually recovering lo control levels (Figure 7). In the same dogs the response to
submaximal stimulation of the right vagus nerve was enhanced by veratridine, with
gradual recovery to the control response (Figure 8). For either stellate or vagal
stimulation the effect of veratridine was unrelated to and considerably outlasted its
primary chronotropic action.
DISCUSSION

On direct perfusion of the sinus node of the dog both veratridine and veratramine
have distinct chronotropic effects which are the same for both substances. The observation that both veratridine and veratramine caused sinus tachycardia when administered
in Ringer's solution but sinus bradycardia when administered in blood is of potential
significance in interpreting the results obtained by previous investigators utilizing isolated
tissue or heart-lung preparations, some of which have been perfused with blood and
others by various "physiologic" solutions.
The absence of reflex aortic hypotension following injection of veratridine or
veratramine into the sinus node artery supplements the observations of Dawes"
on receptor sites for the coronary chemoreflex. He demonstrated that the reflex could
be elicited by injections into the coronary arteries supplying the left ventricle, but not
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\ Veratfidine 1.0pg (in Ringer's)

Figure 6
Periodic rhythm observed with second injections of either veratridine or veratramine 1.0 /ig is
illustrated in this continuous ECG (lead a VR); the letters serve only to identify the lines. Periodic
rhythm seen when utilizing the preparation employed in these studies differs from periodic rhythm
seen after systemic administration of veratridine in that the intervals during sinus arrest are usually
filled by an escape A-V nodal rhythm, since the A-V nodal pacemaker is unaffected during direct perfusion of the sinus node. Injection was begun at the arrow in line A and completed in line D. The
initial sinus acceleration, lines A to D, terminates in abrupt bradycardia in line E, followed by an
escape A-V nodal rhythm alternating with brief resumptions of sinus rhythm until recovery in line L.
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by injections into those supplying the left atrium or right ventricle. In view of the
abundant innnervation of the sinus node^ it is of some interest that there do not appear
to be receptor sites for the reflex in the area supplied by the sinus node artery, which
perfuses not only the sinus node but several centimeters of adjacent right atrial
myocardium''^.
Since an antiaccelerator action of veratrum alkaloids has been demonstrated to
exist against numerous sympathomimetic amines as well as against accelerator nerve
stimulation'"", it may be presumed that this action cannot occur exclusively at the nerve

RIGHT STELLATE STIMULATION
AFTER INTRANODAL VERATRIDINE
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Figure 7
The antiaccelerator action of 1.0 fig intranodal veratridine (in Ringer's) is demonstrated in this
experiment. Each vertical line indicates the response to supramaximal stellate ganglion stimulation
and extends from the prestimulus rate indicated by a bar to the peak response indicated by a dot.
The first stimulus after veratridine evoked no acceleration, while the response at 27 minutes was
virtually back to control (C). The minutes on the horizontal axis refer to time after veratridine.
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ending (although it may act there also) but must include the effector site. On the other
hand a prominent feature of the histopathology in poisoning by veratrum alkaloids
derived from sabadilla seeds is reported to be structural damage of nerves, with disintegration of ganglion cells and demyelinization of peripheral nerve fibers". From these
and related observations it seems likely that veratrum alkaloids act both on sinus node
fibers and local nerve endings, although the enhancement of response to vagal stimulation in our experiments suggests that the local parasympathetic ganglia are not initially
damaged.

RIGHT VAGAL STIMULATION
BEFORE AND AFTER INTRANODAL VERATRIDINE
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Figure 8
Intranodal veratridine (in Ringer's) enhanced the response to submaximal vagal stimulation. The
responses to stimulation in this dog are plotted in the same manner as Figure 7. After 0.1 and 0.5 /ng
of veratridine there was slightly increased response to vagal stimulation, but the response to an
identical stimulus following 1.0 ^ig was much increased over control (C). The response then gradually
returned to control at 43 minutes and remained consistent for 20 more minutes. The minutes indicate
Lime after the control response.
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Concerning the accelerator action of veratridine or veratramine in dogs with intact
vagi, there is considerable evidence that these alkaloids can release catecholamines".
In our experiments serial injections of veratridine or veratramine in Ringer's solution
did not continue producing sinus tachycardia, whereas serial injections of norepinephrine
at the same intervals in this preparation do'. Similarly, repeated stimulations of the
right stellate ganglion at these intervals continue to evoke maximum accelerative
responses. The continued maximum responses to norepinephrine indicate the normal
sinus node does not lose its ability to respond to local injection of this neurohormone,
while the responses to stellate ganglion stimulation suggest the normal nodal adrenergic
nerve endings do not lose their ability to liberate norepinephrine. Serial injections of
veratridine and veratramine in Ringer's solution must, therefore, do more than simply
liberate local norepinephrine.
If the acceleration from these two substances when administered in Ringer's solution is due to local release of norepinephrine, as all features of the graphed curves of
heart rate response suggest (Figure 2), and as might be anticipated from other studies
demonstrating the ability of certain veratrum alkaloids to release catecholamines", then
the following considerations may be made. First injections of Ringer's solution directly
into the sinus node artery are regularly followed by a modest post-injection acceleration
which is seldom seen after injections of blood. This post-injection acceleration is
abolished by either the dichloro or naphthyl analog of isoproterenol'* ", suggesting
it may be due to norepinephrine locally released in the node by the calcium" in Ringer's
solution. Thus injections in Ringer's solution may cause local release of some norepinephrine while those in blood may not. Second, in Ringer's solution all the calcium is in
ionized form whereas only half that in whole blood is ionizable, and Dawes"
has demonstrated that the calcium ion opposes several cardiovascular effects of
veratridine. It is possible then that veratridine or veratramine exert a direct negative
chronotropic effect when given in blood, but that this effect is opposed by the presence
of ionizable calcium in comparatively large amount in Ringer's solution, leaving apparent
only the effect of norepinephrine released locally by both Ringer's solution itself and
the veratridine or veratramine. Further studies will be required to establish whether
these or still other factors are in fact responsible for the chronotropic responses observed
in our experiments.
SUMMARY

Veratridine and veratramine have similar chronotropic effects when studied by
direct perfusion of the canine sinus node through its own artery, but the effects of
either substance differ according to whether administered in Ringer's solution or blood.
Both veratridine and veratramine in Ringer's solution have a sinus accelerating effect,
but in blood have a sinus slowing effect. Serial injections of either substance in either
Ringer's solution or blood lead first to periodic rhythm and then sinus arrest.
Veratridine administered by direct perfusion of the sinus node suppresses the response
to stellate ganglion stimulation and enhances the response to vagal stimulation. The
absence of reflex hypotension following injection of veratridine or veratramine into
the sinus node artery indicates the area perfused by that vessel probably does not
contain receptors for the coronary chemoreflex of Von Bezold and Jarisch.
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